SSY — SunLink Health Systems Share Price
Last trade - 00:00- $6.31m
- -$1.71m
- $32.44m
- 79
- 77
- 59
- 83
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.45 | ||
| Price to Tang. Book | 0.49 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.2 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -26.67% | ||
| Return on Equity | -22.06% | ||
| Operating Margin | -12.28% | ||
Financial Summary
| Year End 30th Jun | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 47.81 | 40.69 | 41.34 | 34.28 | 32.44 | n/a | n/a | -6.59% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
SunLink Health Systems, Inc., through subsidiaries, owns and operates healthcare businesses in the Southeast. The Company’s operations are composed of a pharmacy business and an information technology (IT) business. The pharmacy business is composed of four operational areas conducted in three locations in southwest Louisiana: retail pharmacy products and services, consisting of retail pharmacy sales; institutional pharmacy services consisting of the provision of specialty and non-specialty pharmaceutical and biological products to institutional clients or to patients in institutional settings, such as extended care and rehabilitation centers, behavioral and specialty hospitals, hospice, and correctional facilities and durable medical equipment products and services, consisting primarily of the sale and rental of products for institutional clients. Its subsidiary SunLink Health Systems Technology provides information technology (IT) services to outside customers.
Directors
- Robert Thornton CHM (72)
- Mark Stockslager CFO (62)
- Byron Finn CEX (71)
- Sheila Brockman VPR (61)
- Steven Baileys IND (67)
- Gene Burleson IND (80)
- C. Ford IND (82)
- Howard Turner IND (79)
- Last Annual
- June 30th, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- June 9th, 1959
- Public Since
- March 18th, 1980
- No. of Shareholders
- 229
- No. of Employees
- 1,376
- Sector
- Food & Drug Retailing
- Industry
- Consumer Defensives
- Exchange
- NYSE MKT
- Shares in Issue
- 7,040,603
- Address
- SUITE 1120, 900 CIRCLE 75 PARKWAY, ATLANTA, 30339
- Web
- http://www.sunlinkhealth.com/
- Phone
- +1 7709337000
- Auditors
- Cherry Bekaert LLP
Latest News for SSY
Upcoming Events for SSY
Q3 2025 SunLink Health Systems Inc Earnings Release
SunLink Health Systems Inc Annual Shareholders Meeting
Q4 2025 SunLink Health Systems Inc Earnings Release
Similar to SSY
Amcon Distributing Co
NYSE MKT
Healthy Choice Wellness
NYSE MKT
FAQ
As of Today at 23:29 UTC, shares in SunLink Health Systems are trading at $0.90. This share price information is delayed by 15 minutes.
Shares in SunLink Health Systems last closed at $0.90 and the price had moved by +37.9% over the past 365 days. In terms of relative price strength the SunLink Health Systems share price has outperformed the S&P500 Index by +27.29% over the past year.
There is no consensus recommendation for this security.
Find out moreSunLink Health Systems does not currently pay a dividend.
SunLink Health Systems does not currently pay a dividend.
SunLink Health Systems does not currently pay a dividend.
To buy shares in SunLink Health Systems you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.90, shares in SunLink Health Systems had a market capitalisation of $6.31m.
Here are the trading details for SunLink Health Systems:
- Country of listing: United States
- Exchange: ASQ
- Ticker Symbol: SSY
Based on an overall assessment of its quality, value and momentum SunLink Health Systems is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like SunLink Health Systems. Over the past six months, its share price has underperformed the S&P500 Index by -0.54%.
As of the last closing price of $0.90, shares in SunLink Health Systems were trading +3.21% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The SunLink Health Systems PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.90.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
SunLink Health Systems' management team is headed by:
- Robert Thornton - CHM
- Mark Stockslager - CFO
- Byron Finn - CEX
- Sheila Brockman - VPR
- Steven Baileys - IND
- Gene Burleson - IND
- C. Ford - IND
- Howard Turner - IND